The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
IL-33 reduces the development of atherosclerosis
Open accessAbstract
Atherosclerosis is a chronic inflammatory disease of the vasculature commonly leading to myocardial infarction and stroke. We show that IL-33, which is a novel IL-1–like cytokine that signals via ST2, can reduce atherosclerosis development in ApoE−/− mice on a high-fat diet. IL-33 and ST2 are present in the normal and atherosclerotic vasculature of mice and humans. Although control PBS-treated mice developed severe and inflamed atherosclerotic plaques in the aortic sinus, lesion development was profoundly reduced in IL-33–treated animals. IL-33 also markedly increased levels of IL-4, -5, and -13, but decreased levels of IFNγ in serum and lymph node cells. IL-33 treatment also elevated levels of total serum IgA, IgE, and IgG1, but decreased IgG2a, which is consistent with a Th1-to-Th2 switch. IL-33–treated mice also produced significantly elevated antioxidized low-density lipoprotein (ox-LDL) antibodies. Conversely, mice treated with soluble ST2, a decoy receptor that neutralizes IL-33, developed significantly larger atherosclerotic plaques in the aortic sinus of the ApoE−/− mice compared with control IgG-treated mice. Furthermore, coadministration of an anti–IL-5 mAb with IL-33 prevented the reduction in plaque size and reduced the amount of ox-LDL antibodies induced by IL-33. In conclusion, IL-33 may play a protective role in the development of atherosclerosis via the induction of IL-5 and ox-LDL antibodies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.015 · Cited by 3,710
The immune response in atherosclerosis: a double-edged sword
Hansson, G. K., & Libby, P. (2006) · Nature Reviews Immunology · doi:10.1038/nri1882 · Cited by 2,182
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701
Autoantibody against oxidised LDL and progression of carotid atherosclerosis
Salonen, J. T., Korpela, H., Salonen, R., Nyyssonen, K., Yla-Herttuala, S., Yamamoto, R., Butler, S., Palinski, W., & Witztum, J. L. (1992) · The Lancet · doi:10.1016/0140-6736(92)90926-t · Cited by 1,316
Natural regulatory T cells control the development of atherosclerosis in mice
Ait-Oufella, H., Salomon, B. L., Potteaux, S., Robertson, A.-K. L., Gourdy, P., Zoll, J., Merval, R., Esposito, B., Cohen, J. L., Fisson, S., et al. (2006) · Nature Medicine · doi:10.1038/nm1343 · Cited by 1,100
IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system
Sanada, S., Hakuno, D., Higgins, L. J., Schreiter, E. R., McKenzie, A. N. J., & Lee, R. T. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30634 · Cited by 1,044
Carriere, V., Roussel, L., Ortega, N., Lacorre, D.-A., Americh, L., Aguilar, L., Bouche, G., & Girard, J.-P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606854104 · Cited by 966
IFN-gamma potentiates atherosclerosis in ApoE knock-out mice.
Gupta, S., Pablo, A. M., Jiang, X. C., Wang, N., Tall, A. R., & Schindler, C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119465 · Cited by 868
Löhning, M., Stroehmann, A., Coyle, A. J., Grogan, J. L., Lin, S., Gutierrez-Ramos, J.-C., Levinson, D., Radbruch, A., & Kamradt, T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6930 · Cited by 605
Hörkkö, S., Bird, D. A., Miller, E., Itabe, H., Leitinger, N., Subbanagounder, G., Berliner, J. A., Friedman, P., Dennis, E. A., Curtiss, L. K., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4533 · Cited by 559
Zhou, X., Nicoletti, A., Elhage, R., & Hansson, G. K. (2000) · Circulation · doi:10.1161/01.cir.102.24.2919 · Cited by 554
Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice
Caligiuri, G., Nicoletti, A., Poirier, B., & Hansson, G. K. (2002) · Journal of Clinical Investigation · doi:10.1172/jci7272 · Cited by 530
Selective Expression of a Stable Cell Surface Molecule on Type 2 but Not Type 1 Helper T Cells
Xu, D., Chan, W. L., Leung, B. P., Huang, F.-P., Wheeler, R., Piedrafita, D., Robinson, J. H., & Liew, F. Y. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.5.787 · Cited by 512
Self-citationIdentification of Serum Soluble ST2 Receptor as a Novel Heart Failure Biomarker
Weinberg, E. O., Shimpo, M., Hurwitz, S., Tominaga, S.-I., Rouleau, J.-L., & Lee, R. T. (2003) · Circulation · doi:10.1161/01.cir.0000047274.66749.fe · Cited by 503
Binder, C. J., Hartvigsen, K., Chang, M.-K., Miller, M., Broide, D., Palinski, W., Curtiss, L. K., Corr, M., & Witztum, J. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420479 · Cited by 452
Davenport, P., & Tipping, P. G. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63471-2 · Cited by 444
Shimpo, M., Morrow, D. A., Weinberg, E. O., Sabatine, M. S., Murphy, S. A., Antman, E. M., & Lee, R. T. (2004) · Circulation · doi:10.1161/01.cir.0000127958.21003.5a · Cited by 411
Interleukin-18 Enhances Atherosclerosis in Apolipoprotein E −/− Mice Through Release of Interferon-γ
Whitman, S. C., Ravisankar, P., & Daugherty, A. (2002) · Circulation Research · doi:10.1161/hh0202.105292 · Cited by 385
T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses
Buono, C., Binder, C. J., Stavrakis, G., Witztum, J. L., Glimcher, L. H., & Lichtman, A. H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409015102 · Cited by 358
B-Lymphocyte Deficiency Increases Atherosclerosis in LDL Receptor–Null Mice
Major, A. S., Fazio, S., & Linton, M. F. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000039169.47943.ee · Cited by 329
IL‐33 is a chemoattractant for human Th2 cells
Komai‐Koma, M., Xu, D., Li, Y., McKenzie, A. N. J., McInnes, I. B., & Liew, F. Y. (2007) · European Journal of Immunology · doi:10.1002/eji.200737547 · Cited by 319
Self-citationImpact of Interleukin-6 on Plaque Development and Morphology in Experimental Atherosclerosis
Schieffer, B., Selle, T., Hilfiker, A., Hilfiker-Kleiner, D., Grote, K., Tietge, U. J. F., Trautwein, C., Luchtefeld, M., Schmittkamp, C., Heeneman, S., et al. (2004) · Circulation · doi:10.1161/01.cir.0000148135.08582.97 · Cited by 288
Sweet, M. J., Leung, B. P., Kang, D., Sogaard, M., Schulz, K., Trajkovic, V., Campbell, C. C., Xu, D., & Liew, F. Y. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6633 · Cited by 248
Self-citationEfficient and Selective AAV2-Mediated Gene Transfer Directed to Human Vascular Endothelial Cells
Nicklin, S. A., Buening, H., Dishart, K. L., de Alwis, M., Girod, A., Hacker, U., Thrasher, A. J., Ali, R. R., Hallek, M., & Baker, A. H. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0424 · Cited by 219
Self-citationHashmi, S., & Zeng, Q. T. (2006) · Coronary Artery Disease · doi:10.1097/01.mca.0000236288.94553.b4 · Cited by 191
Quantification of Atherosclerosis in Mice
Daugherty, A., & Whitman, S. C. (2003) · Transgenic Mouse Methods and Protocols · doi:10.1385/1-59259-340-2:293 · Cited by 179
Interleukin 5 and B cell differentiation
Takatsu, K. (1998) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00034-8 · Cited by 116
Cytokine secretion profiles of cloned T cells from human aortic atherosclerotic plaques
de Boer, O. J., van der Wal, A. C., Verhagen, C. E., & Becker, A. E. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199906)188:2<174::aid-path333>3.0.co;2-3 · Cited by 98
Antibodies to oxidized LDL in atherosclerosis development—clinical and animal studies
Hulthe, J. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.05.021 · Cited by 79
Tous, M., Ribas, V., Escolá‐Gil, J. C., et al. (2006) · Cytokine · doi:10.1016/j.cyto.2006.05.007 · Cited by 15
Cited by
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466
The immune system in atherosclerosis
Hansson, G. K., & Hermansson, A. (2011) · Nature Immunology · doi:10.1038/ni.2001 · Cited by 2,317
The interleukin-1 family: back to the future
Garlanda, C., Dinarello, C. A., & Mantovani, A. (2013) · Immunity · doi:10.1016/j.immuni.2013.11.010 · Cited by 1,945
Immune and Inflammatory Mechanisms of Atherosclerosis
Galkina, E., & Ley, K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132620 · Cited by 1,437
Moussion, C., Ortega, N., & Girard, J.-P. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003331 · Cited by 1,179
Metadata
- Authors
- Miller, A. M., Xu, D., Asquith, D. L., Denby, L., Li, Y., Sattar, N., Baker, A. H., McInnes, I. B., & Liew, F. Y.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2008-02-11
- Volume
- 205
- Issue
- 2
- Pages
- 339-346
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2168381900
- Cited by
- 642
- References
- 30
- FWCI
- 13.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.